Literature DB >> 12567258

[Drug interactions in clinical practice. A pilot project for quality assurance in prescribing].

U Geppert1, W Beindl, T Hawranek, H Hintner.   

Abstract

BACKGROUND AND
OBJECTIVE: The aim of the project was to document and evaluate the safety of combinations of drugs prescribed during hospitalization, producing a method of quality assurance assessment. PATIENTS/
METHODS: The medications of 396 patients already taken at home as well as the drugs given in the hospital during an acute illness were analyzed. Potential drug interactions were detected using a computerized drug-interaction checking system i.e. Micromedex CD-ROM database DRUG-REAX. This program differentiates between contraindicated, major, moderate or minor interactions.
RESULTS: No contraindicated combinations of medications were found but in 265 instances (66,9%) potentially relevant ( major or moderate) combinations could be detected. There was a correlation between potentially dangerous drug combinations and the number of coadministered drugs. Despite the detection of a large number of potentially troublesome combinations, no significant clinical problems were observed over at least three days of observation.
CONCLUSIONS: The number of potentially relevant drug interactions represents a severe problem in drug prescribing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12567258     DOI: 10.1007/s00105-002-0439-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  18 in total

1.  Preventable sudden death in patients receiving angiotensin converting enzyme inhibitors and loop/potassium sparing diuretic combinations.

Authors:  R T Johnston; D P de Bono; C R Nyman
Journal:  Int J Cardiol       Date:  1992-02       Impact factor: 4.164

2.  Heart failure: highlights from new consensus guidelines.

Authors:  J Young
Journal:  Cleve Clin J Med       Date:  2000-01       Impact factor: 2.321

3.  New strategies for improving heart failure management: a primary care perspective.

Authors:  J Basile
Journal:  South Med J       Date:  2001-02       Impact factor: 0.954

4.  Frequency of hypomagnesemia in hospitalized patients receiving digitalis.

Authors:  R Whang; T O Oei; A Watanabe
Journal:  Arch Intern Med       Date:  1985-04

5.  Fever, myalgia, and arthralgia in a patient on captopril and allopurinol.

Authors:  A Samanta; A C Burden
Journal:  Lancet       Date:  1984-03-24       Impact factor: 79.321

6.  Diuretic-induced hypokalemia.

Authors:  J P Knochel
Journal:  Am J Med       Date:  1984-11-05       Impact factor: 4.965

7.  Effectiveness of digitoxin versus trichlormethiazide/amiloride in congestive heart failure NYHA class II/III and sinus rhythm.

Authors:  M Huonker; S Sorichter; A Schmidt-Trucksäss; M Irmer; J Staiger; J Keul
Journal:  Cardiovasc Drugs Ther       Date:  1999-05       Impact factor: 3.727

8.  Chronic heart failure. Examining consensus recommendations for patient management.

Authors:  J M Makalinao; S D Fields
Journal:  Geriatrics       Date:  2000-12

Review 9.  Lethal combination of tramadol and multiple drugs affecting serotonin.

Authors:  M G Ripple; J P Pestaner; B S Levine; J E Smialek
Journal:  Am J Forensic Med Pathol       Date:  2000-12       Impact factor: 0.921

10.  Methotrexate toxicity precipitated by azapropazone.

Authors:  H M Daly; G L Scott; J Boyle; C J Roberts
Journal:  Br J Dermatol       Date:  1986-06       Impact factor: 9.302

View more
  5 in total

1.  Risk of digoxin intoxication caused by clarithromycin-digoxin interactions in heart failure patients: a population-based study.

Authors:  Agnes L F Chan; Meng-Ting Wang; Chen-Yi Su; Fu-Hsiung Tsai
Journal:  Eur J Clin Pharmacol       Date:  2009-12       Impact factor: 2.953

2.  Drug Prescription Including Interactions with Anticancer Treatments in the Elderly: A Global Approach.

Authors:  M-E Rougé Bugat; M Bourgouin; S Gérard; S Lozano; D Brechemier; P Cestac; C Cool; L Balardy
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs.

Authors:  R W F van Leeuwen; D H S Brundel; C Neef; T van Gelder; R H J Mathijssen; D M Burger; F G A Jansman
Journal:  Br J Cancer       Date:  2013-02-14       Impact factor: 7.640

4.  Potential drug interactions and duplicate prescriptions among ambulatory cancer patients: a prevalence study using an advanced screening method.

Authors:  Roelof W F van Leeuwen; Eleonora L Swart; Frits A Boom; Martin S Schuitenmaker; Jacqueline G Hugtenburg
Journal:  BMC Cancer       Date:  2010-12-13       Impact factor: 4.430

5.  A pilot study on the impact of known drug-drug interactions in cancer patients.

Authors:  Silvia Ussai; Riccardo Petelin; Antonio Giordano; Mario Malinconico; Donatella Cirillo; Francesca Pentimalli
Journal:  J Exp Clin Cancer Res       Date:  2015-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.